Updates are available Correction dated 2025-06-24
Click to view Correction: https://doi.org/10.1007/s00134-025-08007-8
-
Authors
Puxty, Kathryn https://orcid.org/0000-0002-5742-6171
van Mol, Margo https://orcid.org/0000-0002-0213-6054
Martin Delgado, María Cruz https://orcid.org/0000-0002-7468-4594
Darmon, Michael https://orcid.org/0000-0003-4198-8038
Ferrer, Ricardo https://orcid.org/0000-0002-0392-3631
Galazzi, Alessandro https://orcid.org/0000-0003-0085-7015
Kondi, Entela
Russell, Lene https://orcid.org/0000-0001-7352-8728
Sancho, Elena https://orcid.org/0000-0001-6522-6252
Ostermann, Marlies https://orcid.org/0000-0001-9500-9080
Azoulay, Elie https://orcid.org/0000-0002-8162-1508
Bourne, Richard S. https://orcid.org/0000-0003-0893-525X
- License Information
-
More Information
Article History
Received: 8 February 2025
Accepted: 2 May 2025
First Online: 20 May 2025
Change Date: 24 June 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00134-025-08007-8
Declarations
:
: No conflicts of interests: AG; ES; KP; MCMD; MD; MO; MvM; RB; R. Elie Azoulay has received fees for lectures from Alexion, Sanofi, Pfizer and Gilead.
: Not applicable for this scoping review.
: Not applicable for this scoping review.
